Nord/LB Reiterates “€85.00” Price Target for Fresenius Medical Care AG & Co. KGaA (FME)

Nord/LB set a €85.00 ($98.84) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a report released on Wednesday. The firm currently has a buy rating on the stock.

A number of other brokerages have also commented on FME. HSBC set a €107.00 ($124.42) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Tuesday, August 28th. Berenberg Bank set a €100.80 ($117.21) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Wednesday, July 25th. Barclays set a €86.00 ($100.00) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Monday, July 16th. Goldman Sachs Group set a €98.00 ($113.95) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Friday, August 24th. Finally, Oddo Bhf set a €96.00 ($111.63) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Wednesday, August 1st. Nine equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. The stock has an average rating of Buy and a consensus target price of €92.77 ($107.87).

Shares of ETR:FME opened at €70.10 ($81.51) on Wednesday. Fresenius Medical Care AG & Co. KGaA has a 12 month low of €75.53 ($87.83) and a 12 month high of €93.82 ($109.09).

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Recommended Story: What is a put option?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply